Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 Cases (1989-1999)

Journal of the American Veterinary Medical Association

Volumn 221, Issue 6, 2002, Pages 811-818

  Moore, Antony S ^a   Nelson, Richard W ^b   Henry, Carolyn J ^c   Rassnick, Kenneth M ^a   Kristal, Orna ^a   Ogilvie, Gregory K ^d   Kintzer, Peter ^e  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d Department of Ecosystem Science and Sustainability   (United States)

^e Boston Road Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DIURETIC AGENT; STREPTOZOCIN;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DIURESIS; DOG; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; INSULINOMA; KIDNEY DISEASE; LIVER DISEASE; METASTASIS; NEUTROPENIA; NONHUMAN; PANCREAS ISLET CELL TUMOR; PARANEOPLASTIC NEUROPATHY; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; UREMIA; VOMITING;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037105752     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.221.811     Document Type: Article

References (33)

1. Leifer CE, Peterson ME, Matus RE. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs. J Am Vet Med Assoc 1986;188:60-64.
2. Caywood DD, Klausner JS, O'Leary TP, et al. Pancreatic insulin-secreting neoplasms: clinical, diagnostic, and prognostic features in 73 dogs. J Am Anim Hosp Assoc 1988;24:577-584.
3. Tobin RL, Nelson RW, Lucroy MD, et al. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990-1997). J Am Vet Med Assoc 1999;215:226-230.
4. Kruth SA, Feldman EC, Kennedy PC. Insulin-secreting islet cell tumors: establishing a diagnosis and the clinical course for 25 dogs. J Am Vet Med Assoc 1982;181:54-58.
5. Simpson KW, Stepien RL, Elwood CM, et al. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs. J Small Anim Pract 1995;36:161-165.
6. Stolinsky DC, Sadoff L, Braunwald J, et al. Streptozotocin in the treatment of cancer: phase II study. Cancel 1972;30:61-66.
7. Broder LE, Carter SK. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:108-118.
8. Schein PS, O'Connell MJ, Blom J, et al. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer 1974; 34:993-1000.
9. Handelsman H, Broder LE, Slavik M, et al. Streptozotocin NSC-85998. Rockville, Md: National Cancer Institute, 1974;1-68.
10. Levine BS, Henry MC, Port CD, et al. Toxicologic evaluation of streptozotocin (NSC 85998) in mice, dogs and monkeys. Drug Chem Toxicol 1980;3:201-212.
11. Kaneko JJ, Mattheeuws D, Rottiers RP, et al. Renal function, insulin secretion, and glucose tolerance in mild streptozotocin diabetes in the dog. Am J Vet Res 1978;39:807-809.
12. Meyer DJ. Pancreatic islet cell carcinoma in a dog treated with streptozotocin. Am J Vet Res 1976;37:1221-1223.
13. Meyer DJ. Temporary remission of hypoglycemia in a dog with an insulinoma after treatment with streptozotocin. Am J Vet Res 1977;38:1201-1204.
14. Ogilvie GK. Tumors of the endocrine system. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. Philadelphia: WB Saunders Co, 1996;316-346.
15. Dohson JM, Gorman NT. Complications of chemotherapy. In: Dobson JM, Gorman NT, eds. Cancer chemotherapy in small animal practice. Oxford, UK: Blackwell Scientific Publications, 1993; 67-78.
16. Morrison WB. Cancer in dogs and cats: medical and surgical management. Baltimore: The Williams & Wilkins Co, 1998; 626-629.
17. Frazier DL, Hahn KA. Commonly used drugs. In: Hahn KA, Richardson RC, eds. Cancer chemotherapy. A veterinary handbook. Baltimore: The Williams & Wilkins Co, 1995;79-149.
18. Tobin MV, Warenius HM, Morris AI. Forced diuresis to reduce nephrotoxicity of streptozotocin in the treatment of advanced metastatic insulinoma. Br Med J 1987;294:1128.
19. Kintzel PE. Anticancer drug-induced kidney disorders. Drug Safety 2001;24:19-38.
20. Ogilvie GK, Krawiec DR, Gelberg HB, et al. Evaluation of short-term saline diuresis protocol for the administration of cisplatin. Am J Vet Res 1988;49:1076-1078.
21. Gans JH, Cater MR. Hypercholesterolemia of streptozotocin-induced diabetes mellitus in dogs. Life Sci 1971;10: 301-308.
22. Moore AS, Rand WM, Berg J, et al. Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs. J Am Vet Med Assoc 1994;205:441-443.
23. Rassnick KM, Frimberger AE, Wood CA, et al. Evaluation of ifosfamide for treatment of various canine neoplasms. J Vet Intern Med 2000;14:271-276.
24. Moore AS, London CA, Wood CA, et al. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13:395-398.
25. Tew KD, Colvin M, Chabner BA. Alkylating agents. In: Chabner BA, Longo DL, eds. Cancer chemotherapy and biotherapy. Philadelphia: Lippincott-Raven, 1996;297-332.
26. Fennell JS, Falls WF Jr. Streptozotocin nephrotoxicity: studies on the defect in renal tubular acidification. Clinic Nephrol 1981;15:97-101.
27. Dees JH, Kramer RA. Sequential morphologic analysis of the nephrotoxicity produced in rats by single doses of chlorozotocin. Toxicol Pathol 1986;14:213-231.
28. Hall-Craggs M, Brenner DE, Vigorito RD, et al. Acute renal failure and renal tubular squamous metaplasia following treatment with streptozotocin. Hum Pathol 1982;13:597-601.
29. White FR. Streptozotocin. Cancer Chemother Rep 1963;30: 49-53.
30. Kanter PM, Bullard GA, West CR, et al. Preclinical toxicity study of streptozocin infused into the internal carotid artery of dogs and baboons. J Exp Pathol 1990;5:133-142.
31. Schein PS, Rakieten N, Cooney DA, et al. Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide (37355). Proc Soc Exp Biol Med 1974;143:514-518.
32. Jeffery ND, Maynew IG, Phillips SM. Letter. Prog Vet Neurol 1994;5:135.
33. Van Ham L, Braund KG, Roels S, et al. Treatment of a dog with an insulinoma-related peripheral polyneuropathy with corticosteroids. Vet Rec 1997;141:98-100.